In conclusion, we believe that these long-term findings of NSABP B-17 and B-24 demonstrate that lumpectomy and adjuvant therapies are effective modalities for the treatment of DCIS. It is highly likely that current breast imaging practices, improvements in margin assessments, and advances in adjuvant treatments will continue to reduce the incidence of invasive recurrences after DCIS.

非浸潤性乳管癌の2つの大規模な臨床試験の結果が発表されました（the Journal of the National Cancer Institute 2011年3月16日号）非浸潤性乳管癌の治療として乳房温存療法の妥当性があらためて証明されたと言える結果でした。

(Dec.11,2010,in San Antonio)